Pfizer (PFE), Eli Lilly and Co. (LLY) Report Complete Results from Phase 3 Study of Tanezumab Showing Significant Improvement in Pain & Function in Osteoarthritis Patients
October 24, 2018 5:51 AM
Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) today announced complete results from a Phase 3 study ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
